Posted on 13/07/2010 in Scientific IDS has published its preliminary results for the 2009-10 fiscal year, a period which saw the science company experience improvements in sales and revenue.
During the 12 months ending on March 31st 2010, the firm achieved a revenue total of 37.2 million pounds, up 49 per cent from 2008-09, while earnings were up by 114 per cent in the same time frame.
This performance has extended into the first three months of the new fiscal year, during which revenue has increased by 35 per cent on the year-ago period.
David Evans, chairman of IDS, stated that these improvements are due to the success of products such as its manual vitamin D tests and the IDS-iSYS Immunoanalyser, predicting this trend will continue in the coming months.
He said: "I feel that the opportunities laid at our feet as a result of having the IDS-iSYS are very exciting and I look forward to updating you throughout the year on its progress."
This week has also seen IDS announce that Roger Duggan will step down as chief executive officer on October 1st 2010, when he will be replaced by current chief operating officer Ian Cookson.Other news stories from 13/07/2010
Read more in the Zenopa News Archive
How this news is generated
|
